These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7492542)

  • 1. Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence.
    Katz BA
    Biochemistry; 1995 Nov; 34(47):15421-9. PubMed ID: 7492542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In crystals of complexes of streptavidin with peptide ligands containing the HPQ sequence the pKa of the peptide histidine is less than 3.0.
    Katz BA; Cass RT
    J Biol Chem; 1997 May; 272(20):13220-8. PubMed ID: 9148939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topochemical catalysis achieved by structure-based ligand design.
    Katz BA; Cass RT; Liu B; Arze R; Collins N
    J Biol Chem; 1995 Dec; 270(52):31210-8. PubMed ID: 8537386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities.
    Giebel LB; Cass RT; Milligan DL; Young DC; Arze R; Johnson CR
    Biochemistry; 1995 Nov; 34(47):15430-5. PubMed ID: 7492543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of the streptavidin binding loop.
    Freitag S; Le Trong I; Klumb L; Stayton PS; Stenkamp RE
    Protein Sci; 1997 Jun; 6(6):1157-66. PubMed ID: 9194176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin.
    Schmidt TG; Koepke J; Frank R; Skerra A
    J Mol Biol; 1996 Feb; 255(5):753-66. PubMed ID: 8636976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of biotin to streptavidin stabilizes intersubunit salt bridges between Asp61 and His87 at low pH.
    Katz BA
    J Mol Biol; 1997 Dec; 274(5):776-800. PubMed ID: 9405158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure and ligand-binding studies of a screened peptide complexed with streptavidin.
    Weber PC; Pantoliano MW; Thompson LD
    Biochemistry; 1992 Oct; 31(39):9350-4. PubMed ID: 1390720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
    Meyer SC; Gaj T; Ghosh I
    Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topochemistry for preparing ligands that dimerize receptors.
    Katz BA; Stroud RM; Collins N; Liu B; Arze R
    Chem Biol; 1995 Sep; 2(9):591-600. PubMed ID: 9383463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using surface plasmon resonance to directly determine binding affinities of combinatorially selected cyclopeptides and their linear analogs to a streptavidin chip.
    Chang YP; Chu YH
    Anal Biochem; 2005 May; 340(1):74-9. PubMed ID: 15802132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
    Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
    J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal Structures of Protein-Bound Cyclic Peptides.
    Malde AK; Hill TA; Iyer A; Fairlie DP
    Chem Rev; 2019 Sep; 119(17):9861-9914. PubMed ID: 31046237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of avidin and streptavidin binding motifs among peptides selected from a synthetic peptide library consisting solely of D-amino acids.
    Gissel B; Jensen MR; Gregorius K; Elsner HI; Svendsen I; Mouritsen S
    J Pept Sci; 1995; 1(4):217-26. PubMed ID: 9222999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction.
    Wu SC; Ng KK; Wong SL
    Proteins; 2009 Nov; 77(2):404-12. PubMed ID: 19425108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural consensus in ligand-protein docking identifies recognition peptide motifs that bind streptavidin.
    Shah NK; Rejto PA; Verkhivker GM
    Proteins; 1997 Jul; 28(3):421-33. PubMed ID: 9223187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of two cyclic pseudopentapeptides containing psi[CH2S] and psi[CH2SO] backbone surrogates.
    Ma S; Richardson JF; Spatola AF
    Biopolymers; 1993 Jul; 33(7):1101-10. PubMed ID: 8343587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.